Switch theme
Sign up to access all valuation multiples
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
1999
1.2K+
LTM Revenue $432M
LTM EBITDA $107M
$3.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cellebrite has a last 12-month revenue (LTM) of $432M and a last 12-month EBITDA of $107M.
In the most recent fiscal year, Cellebrite achieved revenue of $401M and an EBITDA of $67.5M.
Cellebrite expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cellebrite valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $432M | XXX | $401M | XXX | XXX | XXX |
| Gross Profit | $365M | XXX | $339M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 84% | XXX | XXX | XXX |
| EBITDA | $107M | XXX | $67.5M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 17% | XXX | XXX | XXX |
| EBIT | $94.1M | XXX | $56.9M | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | -$133M | XXX | -$283M | XXX | XXX | XXX |
| Net Margin | -31% | XXX | -71% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cellebrite's stock price is $17.
Cellebrite has current market cap of $4.0B, and EV of $3.6B.
See Cellebrite trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.6B | $4.0B | XXX | XXX | XXX | XXX | $-0.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cellebrite has market cap of $4.0B and EV of $3.6B.
Cellebrite's trades at 9.0x EV/Revenue multiple, and 53.3x EV/EBITDA.
Equity research analysts estimate Cellebrite's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cellebrite has a P/E ratio of -30.1x.
See valuation multiples for Cellebrite and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.0B | XXX | $4.0B | XXX | XXX | XXX |
| EV (current) | $3.6B | XXX | $3.6B | XXX | XXX | XXX |
| EV/Revenue | 8.3x | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBITDA | 33.6x | XXX | 53.3x | XXX | XXX | XXX |
| EV/EBIT | 38.2x | XXX | 63.2x | XXX | XXX | XXX |
| EV/Gross Profit | 9.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -30.1x | XXX | -14.1x | XXX | XXX | XXX |
| EV/FCF | 27.1x | XXX | 29.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCellebrite's last 12 month revenue growth is 18%
Cellebrite's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Cellebrite's rule of 40 is -2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cellebrite's rule of X is 70% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cellebrite and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -2% | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 70% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| archTIS | XXX | XXX | XXX | XXX | XXX | XXX |
| FirstWave | XXX | XXX | XXX | XXX | XXX | XXX |
| Prophecy International | XXX | XXX | XXX | XXX | XXX | XXX |
| Qoria | XXX | XXX | XXX | XXX | XXX | XXX |
| Quick Heal | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cellebrite acquired XXX companies to date.
Last acquisition by Cellebrite was XXXXXXXX, XXXXX XXXXX XXXXXX . Cellebrite acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cellebrite founded? | Cellebrite was founded in 1999. |
| Where is Cellebrite headquartered? | Cellebrite is headquartered in United States of America. |
| How many employees does Cellebrite have? | As of today, Cellebrite has 1.2K+ employees. |
| Who is the CEO of Cellebrite? | Cellebrite's CEO is Mr. Thomas E. Hogan. |
| Is Cellebrite publicy listed? | Yes, Cellebrite is a public company listed on NAS. |
| What is the stock symbol of Cellebrite? | Cellebrite trades under CLBT ticker. |
| When did Cellebrite go public? | Cellebrite went public in 2021. |
| Who are competitors of Cellebrite? | Similar companies to Cellebrite include e.g. archTIS, FirstWave, Prophecy International, Qoria. |
| What is the current market cap of Cellebrite? | Cellebrite's current market cap is $4.0B |
| What is the current revenue of Cellebrite? | Cellebrite's last 12 months revenue is $432M. |
| What is the current revenue growth of Cellebrite? | Cellebrite revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of Cellebrite? | Current revenue multiple of Cellebrite is 8.3x. |
| Is Cellebrite profitable? | Yes, Cellebrite is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cellebrite? | Cellebrite's last 12 months EBITDA is $107M. |
| What is Cellebrite's EBITDA margin? | Cellebrite's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Cellebrite? | Current EBITDA multiple of Cellebrite is 33.6x. |
| What is the current FCF of Cellebrite? | Cellebrite's last 12 months FCF is $133M. |
| What is Cellebrite's FCF margin? | Cellebrite's last 12 months FCF margin is 31%. |
| What is the current EV/FCF multiple of Cellebrite? | Current FCF multiple of Cellebrite is 27.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
